Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Atakan Demir Nil Molinas Mandel Semra Paydaş Gökhan Demir Ozlem Er Nazım Serdar Turhal Sevil Bavbek Yeşim EralpPınar Mualla SaipEmine Nilüfer Güler Adnan Aydıner Başak Oyan Uluç Saadettin Kılıçkap Necdet Üskent Nuri Karadurmus Muhammet Ali Kaplan Mustafa Teoman Yanmaz Hacer Demir Özkan Alan Taner Korkmaz Polat Olgun Özlem Sönmez Kadri Altundag Seyda Gunduz Meral Günaldı Murat Sarı Ismail Beypinar Gül Başaran

Published in: Balkan medical journal (2020)

The efficacy of palbociclib among heavily treated hormone receptor-positive/HER2− patients with advanced breast cancer was acceptable in terms of clinical benefit, and it was generally well tolerated among this population.

Keyphrases

cross sectional
metastatic breast cancer
young adults
combination therapy
replacement therapy
smoking cessation
childhood cancer